Up First from NPR Folgen

Israel's government is considering expanding the war in Gaza despite a growing chorus of voices in Israel calling for an immediate end to the war, Texas Republicans are threatening to arrest Democratic lawmakers unless they return to the statehouse for a redistricting vote, and the Trump administration has plans to end two satellite missions that measure carbon dioxide in the atmosphere.Want more comprehensive analysis of the most important news of the day, plus a little fun? Subscribe to the Up First newsletter. Today's episode of Up First was edited by Hannah Bloch, Larry Kaplow, Neela Bannerjee, Janaya Williams and Alice Woelfle. It was produced by Ziad Buchh, Nia Dumas and Christopher Thomas. We get engineering support from Damian Herring. And our technical director is Carleigh Strange. Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

New and higher import tariffs are set to take effect this week, but Mexico got a 90 day reprieve, causing uncertainty among companies who rely on cross-border business. Also, President Trump is working to reach a deal to bring Israeli hostages home, as international pressure grows to stop the starvation and bombardment in Gaza.Want more comprehensive analysis of the most important news of the day, plus a little fun? Subscribe to the Up First newsletter. Today's episode of Up First was edited by Rafael Nam, Russell Lewis, Hannah Bloch, Janaya Williams and Alice Woelfe. It was produced by Ziad Buchh, Nia Dumas and Christopher Thomas. We get engineering support from Stacey Abbott. And our technical director is Carleigh Strange. Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Research shows that psychedelics can help with a range of mental health conditions, like PTSD and depression. So why can't you get them from your doctor? Today on The Sunday Story, we take a trip through some of the latest science behind psychedelic therapy, and efforts to bring these mind‑altering drugs into the mainstream. Plus, what's ketamine got to do with it?Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy